Important matters:
Nason Technology (02261) plans to sell 57.5945 million shares globally and is expected to be listed on August 7
Zhongji Xuchuang (03308): An international sale with an offering price of HK$980 per share received 9.73 times the subscription
Hengrui Pharmaceutical (01276) approved for marketing, a Class 1 therapeutic biological product, the self-developed suldi insulin injection
China Resources Shuanghe, a subsidiary of China Resources Pharmaceutical (03320), plans to acquire about 23.5% of Lier Chemical's shares for 5.656 billion yuan
Quanxin Bio-B (02509) partner Caldera Therapeutics plans to merge with Synlogic to list on NASDAQ and raise US$278 million at the same time
COSCO HAIFA (02866) plans to spend 7.92 billion yuan to acquire a total of 15 ships
Minglue Technology-W (02718) subsidiary plans to acquire about 19.07% of Pulian Software's shares for 859 million yuan
Zijin Mining (02899): Zijin Gold International (02259) terminated the acquisition of United Gold and plans to acquire 9.2% of its shares by subscribing for targeted additional shares
Volkswagen Public Transport (01635), Public Transport, and Beijing Motion jointly signed a “Partnership Agreement” to jointly fund the establishment of Wuxi Luyao
Zhongmiao Holdings (01471) and Zhongan Online (06060) signed a strategic cooperation agreement to establish a long-term, stable and comprehensive strategic partnership
Operating performance:
Standard Chartered Group (02888) announced 2026 interim results, with profit before tax of US$4.8 billion, an increase of 9% over the previous year
HKT-SS (06823) Announces Interim Results Profit attributable to share holders increased 4% year-on-year to HK$2.153 billion with HK$34.8 cents per share
Budweiser Asia Pacific (01876) announced 2026 interim results. Profit attributable to equity holders was US$473 million, an increase of 15.6% over the previous year
New Oriental-S (09901) announced annual results, net profit attributable to shareholders of US$475 million, an increase of 27.8% year-on-year
MGM China (02282)'s total revenue for the first half of the year was HK$17.392 billion, up 4.4% year over year
Fosun International (00656) Fosun International (00656) expects mid-term profit of about 1.5 billion yuan to 1.8 billion yuan, a year-on-year increase of about 127% to 172%
Ruibo Bio-B (06938) is expected to achieve revenue of about 311 million to 436 million yuan in the first half of the year, an increase of about 200% to 320% year-on-year
Jushuitan (06687) Fa Yingxi expects shareholders' profit to be about 100 million yuan to 130 million yuan in the first half of the year
Jiufang Smart Investment Holdings (09636) anticipates net profit attributable to shareholders in the medium term of 25 million yuan to 35 million yuan
Zhongmiao Holdings (01471) Fa Yingxi expects the profit attributable to shareholders in the medium term to exceed 35.5 million yuan, an increase of more than 40% year-on-year